AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06661369 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensory Perceptual Motor Training on Individual
Description: 1. Sensory Input~   * Wheelbarrow walks, swimming, and drying off.~2. Proprioceptive~   * Climbing, pushing, pulling, and carrying heavy objects.~3. Vestibular~   * Swinging, trampolining, and playground games.~4. Tactile~   * Stereognosis training, textured paths, and messy play (mud, sand).~5. Motor Planning~   * Statue spinning, crawling through/under objects, and quick movements.~6. Balance and Posture~   * Various balance positions (e.g., hands and knees).~7. Ocular Control~   * Catching and tossing balls.~8. Bilateral Coordination~   * Activities using both sides of the body (e.g., stick ball).~9. Visual-Spatial~   * Walking, stair climbing, and puzzles.~10. Fine Motor Skills~    * Puzzles, bead stringing, and drawing.~11. Gross Motor~    * Standing, walking, running, and throwing games.
Study NCT05698745 — intervention group
Intervention type: PROCEDURE
Intervention: bioespecimen samples
Description: Blood, serum, plasma, urine, stools, small/large bowel tissue.
Study NCT04873934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inclisiran
Description: Inclisiran sodium 300 mg / 1.5 ml (equivalent to 284 mg of inclisiran)
Study NCT05145504 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Evaluation of IL-6 biomarkers in synovial fluid
Description: Evaluation of IL-6 biomarkers in synovial fluid in obese and normal weight patients with gonarthrosis
Study NCT06066333 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Ablative Radiotherapy
Description: All participants will first undergo ablative RT
Study NCT06066333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: After completion of ablative RT, all subjects may begin pembrolizumab treatment
Study NCT03919162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PQ912
Description: PQ912 150 mg tablets
Study NCT03919162 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets to mimic PQ912 150 mg tablets
Study NCT05488522 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SBRT + atezolizumab and bevacizumab
Description: Stereotactic Body Radiotherapy (SBRT) is a radiation procedure that delivers precise doses of radiation in fractions. See following section for more information on the schedule, dose, volume, and simulation of SBRT.~Atezolizumab is an FDA-approved immune checkpoint inhibitor that is used in the treatment of advanced HCC. It is administered as a flat-dose 1200 mg intravenous infusion every three weeks.~Bevacizumab is an FDA-approved anti-VEGF monoclonal antibody that is used in the treatment of advanced HCC in combination with atezolizumab. It is administered as a weight-based dose of 15 mg/kg intravenous infusion every 3 weeks.
Study NCT06418282 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dayspring
Description: NPCD
Study NCT06124664 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Radionuclide venography
Description: With the patient in an upright position, 370 MBq of 99mTc pertechnetate is injected into one of the dorsal veins of the foot after applying a tourniquet in the area of the ankle joint. Then, with the help of a gamma camera detector, the movement of the radiopharmaceutical is monitored in the following segments: tibial (muscular-venous pump of the lower leg), popliteal, femoral and iliocaval. To study the evacuation function of the muscular-venous pump (MVP) of the leg, using an analytical computer program, areas of interest are identified in the tendon, muscle parts of the veins of the leg and the popliteal vein. The time of evacuation of the radiopharmaceutical from the MVP of the leg is estimated - the average transport time of the isotope.
Study NCT06124664 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: single-photon emission computed tomography
Description: SPECT of the pelvic veins with in vivo-labelled red blood cells (RBCs). For radionuclide assessment of the state of the pelvic veins, 2 ml of Perfotech solution is injected into the cubital vein for subsequent labeling of red blood cells in vivo. In 20 minutes. 370 MBq of 99mTc-pertechnetate is injected into one of the veins of the dorsum of the foot and radionuclide venoscintigraphy is performed according to the method presented above. 20 minutes after the administration of the radiopharmaceutical and the venography, SPECT of the pelvic veins is performed. Tomography of the distribution of labeled erythrocytes in the pelvic veins is carried out in a circular orbit with the gamma camera detector rotated 360°. The analysis of the obtained information is carried out using the standard ECT Protocol software package, which allows obtaining sections in 3 projections (sagittal, transversal and coronal) with a slice step of 8 mm.
Study NCT06700330 — intervention group
Intervention type: OTHER
Intervention: no intervention, observational study
Description: Only data from the patient file.
Study NCT06705426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular mobilization with addition anterior, posterior ,caudal glenohumeral mobilization, infrared therapy, ultrasound therapy, pendulum exercises
Description: Scapular mobilization with addition anterior, posterior ,caudal glenohumeral mobilization, infrared therapy, ultrasound therapy, pendulum exercises
Study NCT06705426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Posterior capsular stretch with addition anterior, posterior ,caudal glenohumeral mobilization, infrared therapy, ultrasound therapy, pendulum exercises
Description: Posterior capsular stretch with addition anterior, posterior ,caudal glenohumeral mobilization, infrared therapy, ultrasound therapy, pendulum exercises
Study NCT06727552 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Barzolvolimab
Description: Subcutaneous Administration
Study NCT06727552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching placebo
Description: Subcutaneous Administration
Study NCT06722365 — intervention group
Intervention type: DEVICE
Intervention: Backscatter Quantitative Ultrasound
Description: The intervention consists of a regular abdominal ultrasound scan for fetal evaluation. The difference with a regular scan is that the scanner used to image the fetus provides access to raw/unprocessed ultrasound echo data that can be extracted from the scanner and processed offline (after acquisition) to extract compute backscatter quantitative ultrasound (bQUS) features. Thus, data acquisition does not represent a significant departure from conventional fetal imaging protocols. Other than the time needed to acquire the images, the participant will not perceive any difference from a regular fetal ultrasound scan.
Study NCT06726941 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy and Rehabilitation Practices
Description: It was planned to give the participants a routine stroke rehabilitation program consisting of 45 minutes of active, passive range of motion exercises and strengthening exercises, balance exercises, walking training and 20 minutes of bicycle ergometry, accompanied by a physiotherapist with at least 5 years of experience in stroke rehabilitation. It was planned to give passive bicycle ergometry to patients without voluntary muscle movement and muscle strength, and active bicycle ergometry to participants with voluntary muscle movement and muscle strength, with the bicycle rehabilitation. It was planned to apply the exercise program to the patients for 5 days a week and for a total of 30 sessions. It will be recommended that they continue the medical treatment they are using during the treatment program. Routine evaluations will be made by the physiatrist before the rehabilitation program starts and 2 tubes of venous blood will be taken from the patients by an experienced nurse
Study NCT06745804 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 68Ga-R10602 injection
Description: 68Ga-R10602 is a gallium-labeled small molecule radioligand that is designed to localize tumor lesions in hormone receptor positive breast cancer
Study NCT06748547 — intervention group
Intervention type: PROCEDURE
Intervention: scalp nerve block
Description: scalp nerve block is performed bilaterally by an anesthesiologist after induction of anesthesia and 5 minutes before head immobilization, according to the technique described by Pinosky et al. Prepare a syringe (20 mL) for scalp blocks. It is performed using 0.35% bupivacaine and 5 mcg epinephrine (1:2,000,000) using a 23-gauge needle inserted at a 45° angle to the skin and penetrating deeply into the outer edge of the scalp.
Study NCT06749444 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CBT-I
Description: Cognitive therapy tailored for insomnia symptoms.
Study NCT06749444 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CBT
Description: Cognitive behavioral therapy for general psychopathology
Study NCT06750367 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Klapp method exercises
Description: The researcher will administer Klapp method exercises to the participant for a period of 1 month (twice in a week for 50 min .The researcher will perform stretching of upper limb, neck and thoracic region to the participants as a baseline treatment. Klapps exercises program include four point walk followed by two point walk and back walk, breathing exercise from kneeling position, breathing exercise from quadrapedal position, simple bounce glide with simulanteos breathing, bunny hop greeting. Each exercise will be performed with 10 repetitions
Study NCT06750367 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: At-Home exercise program
Description: theywill begiven printed information on an at-home exercise program, such corrective exercises (Chin tuck, stretchingof neck extensormuscles andpectoral musclegroups instandingandsupinepositions) (16) ,posturecorrection exercises(Thisexerciseprogramconsistedof2strengthening(of thedeep cervical flexorsandshoulderretractors)(26) ,andbreathingexercises(Deep breathing is an exercise that can regulate breathing patterns and improve posture. The deep breathing that is done repeatedly can overcome stiffness in the thoracic cage and straighten the curve of thoracic kyphosis)(27).Theywillbeaskedtoperformtheperiodof1month twiceinaweekfor50minwith10repetitionsofeachexercise.
Study NCT06749795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LIV001
Description: Orally administered for 8 weeks
Study NCT06749795 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Orally administered for 8 weeks
Study NCT06750874 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy
Description: One day workshop + telephone booster
Study NCT06747520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ET-26HCl
Description: The dose is 0.8 mg/kg, single dose, Infusion time was 60s ± 5s.
Study NCT06750796 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The Half Swaddling Application
Description: Half swaddling application in term babies
Study NCT06748313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mango Pickle (Water-Based)
Description: The ingredients used in Mango Pickle (Water-based) are Raw mangoes, Carrots, Lemon, Green chili, Gum Berry (Lasora), Grewia asiatica (Phalsa), Sea salt, Fenugreek seeds whole, Fenugreek mashed, Fennel seeds, Chili flakes, Coriander seeds, Turmeric powder, Cumin, Black seeds, Bay leaves, Mashed garlic, Mustard oil, Vinegar, and Water. The pickle's fermentation process will be completed in 6-7 days, and it will be ready to use.
Study NCT06748313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mango Pickle (Oil Based)
Description: The ingredients used in Mango Pickle (Oil-based) are Raw mangoes, Carrots, Lemon, Green chili, Gum Berry (Lasora), Grewia asiatica (Phalsa), Sea salt, Fenugreek seeds whole, Fenugreek mashed, Fennel seeds, Chili flakes, Coriander seeds, Turmeric powder, Cumin, Black seeds, Bay leaves, Vinegar, Mashed garlic, and Mustard oil. The pickle's fermentation process will be completed in 6-7 days, and it will be ready to use.
Study NCT06748313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carrot Pickle (Water-Based)
Description: The ingredients used in Carrot Pickle (Water-Based) are Carrots, Spring garlic, Turmeric, water, mashed mustard seeds, chili powder, salt, and Mustard oil. The pickle's fermentation process will be completed in 2-3 days, and it will be ready to use.
Study NCT06748313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radish Pickle (Water-Based)
Description: The ingredients used in Radish Pickle (Water-Based) are Radish, Spring garlic, Turmeric, water, mashed mustard seeds, chili powder, salt, and Mustard oil. The pickle's fermentation process will be completed in 2-3 days, and it will be ready to use.
Study NCT06748313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Onion Pickle (Water-Based)
Description: The ingredients used in Onion Pickle (Water-Based) are Onion, Vinegar, Turmeric, water, mashed mustard seeds, chili powder, salt, and Mustard oil. The pickle's fermentation process will be completed in 3-4 days, and it will be ready to use.
Study NCT06748313 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lemon & Chili Pickle (Water-Based)
Description: The ingredients used in Lemon \& Chili Pickle (Water-Based) are Lemon, Green Chili, Turmeric, Vinegar, water, and salt. The pickle's fermentation process will be completed in 2-3 days, and it will be ready to use.
Study NCT06749925 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dendritic Cell Vaccine
Description: This intervention distinguishes itself from others by utilizing allogeneic dendritic cells derived from healthy donors fused with autologous tumor cells from patients, which is a novel approach compared to the commonly used autologous DC-based vaccines (DCVax).
Study NCT06749925 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Recent findings have shown that the anti-PD1 monoclonal antibody, a checkpoint inhibitor, can sustainably enhance the anti-tumor immune response. In this study, all patients in the intervention group (vaccine) who reach the fifth dose will be randomized to receive either pembrolizumab or a placebo as an addition to the experimental treatment regimen.
Study NCT06749925 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: In this study, all patients in the intervention group (vaccine) who reach the fifth dose will be randomized to receive either pembrolizumab or a placebo as an addition to the experimental treatment regimen.
Study NCT06748118 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action for therapeutic adherence.
Description: This message is delivered with the aim of modifying the patient's behavior with regard to treatment intake. The research does not anticipate any change in the patient's medical prescriptions.
Study NCT06749899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QL1706
Description: QL1706 5mg/kg will be given every 3 weeks for 3 cycles in induction chemotherapy and for 9 cycles in adjuvant chemotherapy, started on day 1 of induction chemotherapy and adjuvant chemotherapy, respectively.
Study NCT06749899 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine
Description: Gemcitabine 1g/m2, d1 \& 8 of every cycle, every 3 weeks for 3 cycles before radiation.
Study NCT06749899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Gemcitabine 1g/m2, d1 \& 8 of every cycle, every 3 weeks for 3 cycles before radiation.
Study NCT06749899 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Induction cisplatin 80mg/m2, every 3 weeks for 3 cycles before radiation; Concurrent cisplatin 100mg/m2, every 3 weeks for 2 cycles during radiation
Study NCT06749899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Induction cisplatin 80mg/m2, every 3 weeks for 3 cycles before radiation; Concurrent cisplatin 100mg/m2, every 3 weeks for 2 cycles during radiation
Study NCT06749899 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity-modulated radiotherapy
Description: Definitive intensity-modulated radiotherapy (IMRT) of 6996cGy will be given in 33 fractions.
Study NCT06749899 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy
Description: Definitive intensity-modulated radiotherapy (IMRT) of 6996cGy will be given in 33 fractions.
Study NCT06749821 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio Tape
Description: Kinesio tape (KT) is an elastic therapeutic tape used to treat sports injuries and various other disorders. It was first used by Dr. Kenzo Kase in 1979 to relieve pain and promote healing in soft tissues and is a method that is constantly being updated. The KT method is a therapeutic taping technique that relieves pain and facilitates lymphatic drainage by microscopically lifting the skin.
Study NCT06749821 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Tape (Arm 1)
Description: In this application, taping was applied in the same way but with a plaster tape.
Study NCT06749821 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control (no last irrigation)
Description: No application was made.
Study NCT06748261 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CCTAI model
Description: Using a derivative sub-cohort, the investigators aim to first develop an CCTA-based AI-assisted (CCTAI) screening model to distinguish patients with cardiac abnormalities from those normal controls. Second, the investigators target at developing a CCTAI diagnostic model with multi-classification output of cardiomyopathy diagnosis. Both models will be tested in internal validation cohort and external validation cohort.
Study NCT06750393 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Barre exercise along with gym ball exercises
Description: The Barre exercises will be administer to the participant of Group A for a period of 3 month.~Each exercise will be given for 10 s hold × 12 times/set × 3 sets/day × 3 days/week~× 12. Gym ball exercises program include Knee tucks, leg curls, back extension exercises
Study NCT06750393 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Barre exercises
Description: The Barre exercises for a period of 3 month Each exercise will be given for 10 s hold × 12 times/set × 3 sets/day × 3 days/week~× 12. During
Study NCT06749457 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD7760
Description: Participants will receive AZD7760 as a single intravenous infusion.
Study NCT06749457 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will be administered placebo through intravenous infusion.
Study NCT06749457 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be administered placebo through intravenous infusion.
Study NCT05750407 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle change
Description: Three modules target healthy eating, activity, and weight control behaviors
Study NCT05530733 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Pacifier
Description: Pacifiers produced for premature babies will be used in the study. Pacifiers will be made of silicone material suitable for premature baby health and will not contain any harmful substances. A separate pacifier will be used for each baby, and pacifiers will be sterilized before use.
Study NCT05530733 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Breast milk
Description: For babies assigned to the pacifier with breast milk group, their own breast milk will be applied by dripping 1 ml into the pacifier.
Study NCT05641766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THC
Description: Participants will receive THC into a rapidly flowing IV infusion.
Study NCT05641766 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: Participants will receive an equivalent amount (about 1-2 ml) of placebo (sterile 190 proof USP ethanol). The placebo does not produce any measurable blood alcohol levels or subjective/behavioral effects.
Study NCT05794581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CT-868
Description: CT-868
Study NCT05794581 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo as SC Injection
Study NCT05794581 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Victoza
Description: Victoza as active comparator as SC Injection
Study NCT04989803 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Lymphodepleting chemotherapy administered intravenously
Study NCT04989803 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Lymphodepleting chemotherapy administered intravenously
Study NCT04989803 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KITE-363
Description: A single infusion of CAR-transduced autologous T cells administered intravenously
Study NCT04989803 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KITE-753
Description: A single infusion of CAR-transduced autologous T cells administered intravenously
Study NCT06477107 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Soterix® 4x1HD-TDCS
Description: Is intended for inducing cortical neuromodulation for research and treatment purposes.
Study NCT06477107 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Soterix® 1x1 tDCS
Description: At-home remotely supervised transcranial direct current stimulation (tDCS) at an intensity of 2 mA for 20 minutes per session, with slow ramp-up and automatic turn off once it reaches the maximal intensity.
Study NCT06477107 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive training program
Description: Computerized cognitive therapy for 45 minutes per day that starts at the same time with stimulation